Iliac Artery Stent Placement with the Palmaz Stent: Follow-up Study

Murphy, Kenneth D.; Encarnacion, Carlos E.; Le, Van A.; Palmaz, Julio C.

doi:10.1016/s1051-0443(95)72815-9

Cited by 104 publications

(64 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…4 Similar results were reported by Gunther at al 5,6 and Murphy at al 7 Palmaz at al reported that the patency rate for the Palmaz stent at 8.7 months was 92%, and others have made a similar observation. [8][9][10][11][12] In the present study, the initial procedural success and patency rates (95% and 97%, respectively) are comparable with previous reports [4][5][6][7][8][9][10][11][12] and are considered equal to, or even superior to, the results obtained with the Wallstent or Palmaz stents.…”

Section: Discussionsupporting

confidence: 91%

Usefulness of the Symphony Nitinol Stent for Arteriosclerosis Obliterans.

Kinoshita

Suzuki

Hosokawa

et al. 2002

Circ J

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 91%

Usefulness of the Symphony Nitinol Stent for Arteriosclerosis Obliterans.

Kinoshita

Suzuki

Hosokawa

et al. 2002

Circ J

View full text Add to dashboard Cite

“…In contrast, reoperation on aortoiliac vessels can be difficult and result in an unsatisfactory outcome. Our restenosis rate of 8% is comparable to other reports of iliac stenting with Palmaz-Schatz stents [13]. The relatively lower restenosis rate is probably secondary to the larger-caliber vessels at this location.…”

Section: Discussionsupporting

confidence: 85%

“…Procedural mortality rate in our study was 0%, comparable to 0 -0.9% reported in larger series of PalmazSchatz stent insertion in unilateral iliac artery stenosis and abdominal aortic stenosis [13]. The low mortality rate from percutaneous intervention compares favorably to the aggregated 3.3-4.6% surgical mortality rate with aortobifemoral grafting in addition to the lower morbidity and shorter hospital stay [2,14,15].…”

Section: Discussionsupporting

confidence: 78%

Endovascular intervention of aortoiliac occlusive disease in high‐risk patients using the kissing stents technique: Long‐term results

Mouanoutoua

Maddikunta

Allaqaband

et al. 2003

Cathet Cardio Intervent

View full text Add to dashboard Cite

Endovascular intervention deploying a kissing stents (KS) technique has been used as an alternative to surgical intervention in treating symptomatic aortoiliac occlusive disease. However, the long-term results on high-risk patients are unknown. We retrospectively analyzed data on high-risk patients who underwent endovascular intervention using the KS technique at our institution. Fifty high-risk patients aged 62 +/- 6.4 years with severe aortoiliac stenosis underwent stent-supported angioplasty using the KS technique. Thirty percent of the patients had total occlusion of the distal aorta and/or the iliac arteries. Twelve patients received thrombolytics prior to stenting. The procedure was successful in all 50 patients. There was a 4% acute complication rate (distal embolization). However, there were no vascular complications, myocardial infarction, or perioperative death. Primary patency during follow-up of 20 +/- 12.3 months was 92%, while secondary patency rate was 100%. Amputation-free survival was 100%. Ninety-two percent remained free of lifestyle-limiting claudication.

show abstract

“…Recently, endovascular surgery has become established as a widely accepted and clinically useful technique in [17][18][19][20][21][22] A randomized controlled trial (The Dutch Iliac Stent Trial) also showed that, at 2 years, primary patency was 71% for selective stent placement and 70% for primary stent placement. 23 Owing to recent rapid technical and instrumental improvements, it may be expected that stent placement will continue to play an important role in the treatment of iliac CTO lesions.…”

Section: Discussionmentioning

confidence: 99%